HuGE Literature Finder
Records
1
-
2
Lipid lowering and Alzheimer disease risk: A mendelian randomization study. Annals of neurology 2019 11 87 (1): 30-39. Williams Dylan M, Finan Chris, Schmidt Amand F, Burgess Stephen, Hingorani Aroon |
A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations. Brain research 2010 Jul 1344 185-91. Keller Lina, Murphy Charlotte, Wang Hui-Xin, Fratiglioni Laura, Olin Maria, Gafvels Mats, Björkhem Ingemar, Graff Caroline, Meaney Ste |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: